GLMD vs. GOLY
GLMD (Galmed Pharmaceuticals Ltd.) is a stock, while GOLY (Strategy Shares Gold Enhanced Yield ETF) is Nontraditional Bonds fund actively managed by Strategy Shares. Over the past 5 years, GLMD returned -73.19%/yr vs 4.37%/yr for GOLY. Their 0.08 correlation means their historical movements had little consistent relationship.
Performance
GLMD vs. GOLY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GLMD achieves a -17.26% return, which is significantly higher than GOLY's -26.54% return.
GLMD
- 1D
- 3.67%
- 1M
- 8.87%
- 6M
- -12.54%
- YTD
- -17.26%
- 1Y
- -59.94%
- 3Y*
- -63.68%
- 5Y*
- -73.19%
- 10Y*
- -50.77%
- ALL TIME*
- -49.67%
GOLY
- 1D
- -0.68%
- 1M
- -2.80%
- 6M
- -24.07%
- YTD
- -26.54%
- 1Y
- -9.02%
- 3Y*
- 14.14%
- 5Y*
- 4.37%
- 10Y*
- —
- ALL TIME*
- 4.18%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $238.83K | $503.27K | $408.11K | |
| $645.25K | $545.45K | $1.00M |
GLMD vs. GOLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
GLMD Galmed Pharmaceuticals Ltd. | -17.26% | -76.47% | -41.58% | -93.93% | -72.53% | -26.91% |
GOLY Strategy Shares Gold Enhanced Yield ETF | -26.54% | 57.98% | 19.82% | 12.74% | -19.96% | -1.40% |
Correlation
The correlation between GLMD and GOLY is 0.10, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.10 |
Correlation (3Y) Balances recent behavior with more history. | 0.13 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.09 |
Correlation (All Time) Calculated using the full available price history since May 18, 2021 | 0.08 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GLMD vs. GOLY — Risk / Return Rank
GLMD
GOLY
GLMD vs. GOLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Galmed Pharmaceuticals Ltd. (GLMD) and Strategy Shares Gold Enhanced Yield ETF (GOLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GLMD | GOLY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.51 | ||
| Sortino ratioReturn per unit of downside risk | -0.83 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.00 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | -0.87 | -0.15 | -0.72 |
| Martin ratioReturn relative to average drawdown | -1.25 | -0.30 | -0.95 |
Loading charts...
Drawdowns
GLMD vs. GOLY - Drawdown Comparison
The maximum GLMD drawdown since its inception was -99.99%, which is greater than GOLY's maximum drawdown of -37.99%. Use the drawdown chart below to compare losses from any high point for GLMD and GOLY.
Loading charts...
Drawdown Indicators
| GLMD | GOLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -37.99% | -62.00% |
Max Drawdown (1Y)Largest decline over 1 year | -71.21% | -37.99% | -33.22% |
Max Drawdown (3Y)Largest decline over 3 years | -96.89% | -37.99% | -58.90% |
Max Drawdown (5Y)Largest decline over 5 years | -99.92% | -37.99% | -61.93% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | — | — |
Current DrawdownCurrent decline from peak | -99.98% | -36.62% | -63.36% |
Average DrawdownAverage peak-to-trough decline | -76.28% | -12.56% | -63.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 49.60% | 19.14% | +30.46% |
Volatility
GLMD vs. GOLY - Volatility Comparison
Galmed Pharmaceuticals Ltd. (GLMD) has a higher volatility of 23.75% compared to Strategy Shares Gold Enhanced Yield ETF (GOLY) at 6.91%. This indicates that GLMD's price experiences larger fluctuations and is considered to be riskier than GOLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GLMD | GOLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.75% | 6.91% | +16.84% |
Volatility (6M)Calculated over the trailing 6-month period | 76.21% | 30.03% | +46.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 91.92% | 34.02% | +57.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 166.97% | 22.76% | +144.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 138.32% | 22.43% | +115.89% |
Dividends
GLMD vs. GOLY - Dividend Comparison
GLMD has not paid dividends to shareholders, while GOLY's dividend yield for the trailing twelve months is around 9.40%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
GLMD Galmed Pharmaceuticals Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GOLY Strategy Shares Gold Enhanced Yield ETF | 9.40% | 7.22% | 3.85% | 2.94% | 2.57% | 1.11% |
Frequently Asked Questions
GLMD and GOLY have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GLMD has higher volatility (23.75%) compared to GOLY (6.91%). In terms of maximum drawdown, GLMD dropped -99.99% vs GOLY's -37.99%.
GOLY currently has the higher Sharpe Ratio (-0.17 vs -0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GLMD and GOLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer